Eli Lilly's $1.8bn Investment Boosts Irish Manufacturing
Friday, 13 September 2024, 09:00
Investment Highlights in Manufacturing
Eli Lilly has announced a remarkable $1.8 billion investment in its Irish manufacturing operations, aiming to enhance its facilities and increase production capacity.
Limerick Facility Expansion
The company is investing $1 billion in its existing Limerick site to ramp up operations.
Kinsale Facility Development
- Expansion worth $800 million is earmarked for the Kinsale facility.
- This move will significantly boost local job opportunities.
- The investment reflects Eli Lilly's strategic focus on growth in Europe.
This bold step marks a pivotal moment for Eli Lilly as it strengthens its manufacturing footprint in Ireland, signaling robust confidence in the pharmaceutical sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.